Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug 22;396(10250):514-515.
doi: 10.1016/S0140-6736(20)31482-3. Epub 2020 Jul 6.

SARS-CoV-2 seroprevalence in COVID-19 hotspots

Affiliations
Comment

SARS-CoV-2 seroprevalence in COVID-19 hotspots

Isabella Eckerle et al. Lancet. .
No abstract available

PubMed Disclaimer

Comment on

  • Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
    Pollán M, Pérez-Gómez B, Pastor-Barriuso R, Oteo J, Hernán MA, Pérez-Olmeda M, Sanmartín JL, Fernández-García A, Cruz I, Fernández de Larrea N, Molina M, Rodríguez-Cabrera F, Martín M, Merino-Amador P, León Paniagua J, Muñoz-Montalvo JF, Blanco F, Yotti R; ENE-COVID Study Group. Pollán M, et al. Lancet. 2020 Aug 22;396(10250):535-544. doi: 10.1016/S0140-6736(20)31483-5. Epub 2020 Jul 6. Lancet. 2020. PMID: 32645347 Free PMC article.

References

    1. Vetter P, Eckerle I, Kaiser L. Covid-19: a puzzle with many missing pieces. BMJ. 2020;368:m627. - PubMed
    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020 doi: 10.1001/jama.2020.2648. published online Feb 24. - DOI - PubMed
    1. Meyer B, Torriani G, Yerly S. Validation of a commercially available SARS-CoV-2 serological immunoassay. Clin Microbiol Infect. 2020 doi: 10.1016/j.cmi.2020.06.024. published online June 27. - DOI - PMC - PubMed
    1. Xu X, Sun J, Nie S. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nat Med. 2020 doi: 10.1038/s41591-020-0949-6. published online June 5. - DOI - PubMed
    1. Sood N, Simon P, Ebner P. Seroprevalence of SARS-CoV-2-specific antibodies among adults in Los Angeles county, California, on April 10-11, 2020. JAMA. 2020;323:2425–2427. - PMC - PubMed